WASHINGTON: The White House said the ethical issues associated with gene-editing on the human genome need further study by the scientific community and should not be pursued until issues are resolved.
"The administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time," John Holdren, director of the White House Office of Science and Technology Policy, said in a statement.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
